CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 11,438 shares, an increase of ∞ from the June 30th total of 0 shares. Based on an average trading volume of 48 shares, the short-interest ratio is currently 238.3 days.
CanSino Biologics Stock Performance
Shares of OTCMKTS:CASBF opened at C$3.15 on Wednesday. The business has a fifty day moving average price of C$3.04 and a 200-day moving average price of C$3.73. CanSino Biologics has a 1-year low of C$2.60 and a 1-year high of C$6.99.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biopharmaceutical company focused on the research, development and commercialization of vaccine products. Headquartered in Tianjin, the company leverages an adenovirus vector platform to develop single-dose and recombinant vaccines targeting a range of infectious diseases. CanSino’s pipeline includes its authorized COVID-19 vaccine, Convidecia (Ad5-nCoV), as well as candidates for Ebola, influenza and other pathogens.
Since its founding in 2009, CanSino has built end-to-end capabilities spanning antigen discovery, process development and large-scale manufacturing.
Featured Stories
- Five stocks we like better than CanSino Biologics
- UPS Just Gave Investors a Second Chance to Buy
- Welltower at 52-Week Highs—But Analysts Believe There’s More to Come
- D-Wave’s AT&T Deal Shows Quantum Computing Is Moving Beyond Theory
- Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
